Allergan, the global pharmaceutical company, has marked 40 successful years of business in Ireland by confirming an additional investment of €42 million in its Irish operations in 2017. The Company, which employs approximately 1,700 people in Ireland, also announced details of a new €50,000 Innovation Award Programme with Irish colleges around the country. Allergan also announced that it will become the Official Sponsor of the Dubai Duty Free Irish Open hosted by the Rory Foundation as part of a three-year sponsorship. The announcements coincide with the Allergan Global Leadership Team meeting in Dublin.
Allergan operates three facilities in Ireland -- two manufacturing operations, one at Clonshaugh, Dublin and one in Westport, Co. Mayo -- as well as an international supply chain office in Earlsfort Terrace, Dublin. The Westport and Clonshaugh facilities develop and manufacture a range of branded medicines primarily for the export market. This year’s investment of €42 million across its Clonshaugh and Westport manufacturing operations will support increased manufacturing capabilities for some of Allergan’s key current and future products. The investment in Westport will go towards adding additional capacity to its eye care manufacturing operations and the expansion of its ocular implant manufacturing facility to accommodate both a capacity increase for existing products and the capability to accommodate new products using this technology platform, which are currently under development.
Contribution to the Irish Economy
According to Economic Consultants DKM, Allergan has made a significant contribution to the Irish economy since its establishment 40 years ago, with investments in Ireland estimated at a cumulative €610 million to 2017. While the Company primarily manufactures pharmaceutical products for the global market, the firm‘s impact on the local Irish economy is significant, supporting an additional 600 jobs indirectly in the supply chain and 500 jobs in the wider economy.
Allergan’s Chairman, President and Chief Executive Officer, Brent Saunders comments: “As Allergan continues to grow its operations globally, Ireland continues to be a cornerstone of that growth. Our success has been built on strong teams globally, including our highly talented team we have here in Ireland, operating at state-of-the-art manufacturing facilities producing pharmaceutical products for the global market. We are excited to announce continued investment in our Ireland operations, which will help Allergan continue to provide patients in Ireland and around the world with our innovative medicines.”
New Allergan Innovation Award
Since 1977, Allergan has built strong relationships and collaborated closely with local and national Universities and Institutes of Technology, assisting in the design and provision of courses, and providing internships and permanent employment opportunities for students. To coincide with Allergan’s 40th Anniversary, the Company is pleased to announce a new annual €50,000 Innovation Award Programme. The Inaugural Allergan Innovation Award Programme will partner with six Colleges around Ireland, to recognise and support scholars who have excelled through innovative research in the field of Life Sciences.
The six colleges involved in this year’s Innovation Award Programme are Trinity College Dublin, UCD, NUI Galway, IT Sligo, DCU and Galway-Mayo IT.
